Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs EverFit Medical

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and EverFit Medical head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 486 · Grade C

EverFit Medical

Visit EverFit Medical Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 51 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make EverFit Medical a bad call — it's best for people seeking clinic or virtual follow-up who confirm treatment-state eligibility, actual prescription and full payment before booking paid care. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
40
Supply Reliability
95
71
Transparency
90
20
Access Breadth
93
30
Clinical Oversight
92
84
Track Record
88
73
CoreAge RxBrief Score 94 · 51EverFit Medical

Price, coverage & the tracker

CoreAge RxEverFit Medical
Brief Score94/100 (A)51/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

Current medication quote unconfirmed

Named medication discussed without exact preparation, route, supplied quantity or full selected price. Nationwide telehealth and Ohio-only footer conflict.

Consultation fee final after review; non-approval has separate refund rules. Prescription issuance or dispensing/shipment ends ordinary refunds under the summary.

Full price details

Semaglutide weight-care offered; current preparation, route and complete medication quote unknown; no full public selected-program price established

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

Current medication quote unconfirmed

Named medication discussed without exact preparation, route, supplied quantity or full selected price. Nationwide telehealth and Ohio-only footer conflict.

Consultation fee final after review; non-approval has separate refund rules. Prescription issuance or dispensing/shipment ends ordinary refunds under the summary.

Full price details

Tirzepatide weight-care offered; current preparation, route and complete medication quote unknown; no full public selected-program price established

CoverageUS only; restrictions by state, confirmed at intakeOhio clinic and telehealth in all 50 states advertised, while the shared footer limits medical services to Ohio; current treatment-specific eligibility needs confirmation
Brand-name accessNot confirmedThe reviewed pages do not establish a current named branded GLP-1 prescribing program; confirm the exact prescription.
Oral / sublingualInjection onlyUnconfirmed
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

EverFit Medical: Exact preparation and complete quote are unconfirmed. Telehealth advertising promises all 50 states, while the footer limits medical services to Ohio. Consultation review and prescription issuance have separate refund consequences.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.